Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence

NCT00064662 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 655

Last updated 2013-05-10

Study results available
· View outcomes & findings →

Summary

The primary aim of this clinical trial is to compare the treatment success for two surgical procedures that are frequently used and have similar cure rates, yet have not been compared directly to each other in a large, rigorously conducted randomized trial. The secondary aims of the trial are to compare other outcomes for the two surgical procedures, including quality of life, sexual function, satisfaction with treatment outcomes, complications, and need for other treatment(s)after surgery. Follow-up will be a minimum of two years and up to four years.

Conditions

Interventions

PROCEDURE

Burch Modified Tanagho

The Burch colposuspension is a well-established procedure for surgically treating women with stress urinary incontinence. The Burch modified colposuspension suspends the anterior vaginal wall (at the level of the bladder neck) with permanent sutures tied to the iliopectineal ligament.

PROCEDURE

Autologous Fascia Sling

The fascial sling is also a well-established procedure for surgically treating women with stress urinary incontinence. The autologous sling procedure places a harvested strip of rectus fascia transvaginally at the level of the proximal urethra. The fascial strip is secured superiorly to the rectus fascia with permanent sutures

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER
  • University of California, San Diego

    collaborator OTHER
  • University of Maryland

    collaborator OTHER
  • University of Pittsburgh

    collaborator OTHER
  • University of Texas

    collaborator OTHER
  • The University of Texas at San Antonio

    collaborator OTHER
  • University of Utah

    collaborator OTHER
  • Beaumont Hospital

    collaborator OTHER
  • Loyola University

    collaborator OTHER
  • Carelon Research

    lead OTHER

Principal Investigators

  • William D. Steers, M.D. · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-02-28
Primary Completion
2006-06-30
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00064662 on ClinicalTrials.gov